Metraipolis › archive › dc_7b984ed76236

USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I — Europe PMC PMID:41252204

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41252204
DOI
10.1172/jci193162
License (as archived)
solo-consultazione
Archived
2026-11-08T11:22:23.938Z
SHA-256 of the archived text
b5c28258b6c70494105ddc138fd6985430b9ba88512d117f056baa539f078491
Stable URL of this page
https://metraipolis.com/documento/dc_7b984ed76236

How to cite

USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I — Europe PMC PMID:41252204 — Europe PMC (en), https://europepmc.org/article/MED/41252204 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b984ed76236 (Metraipolis archive dc_7b984ed76236, sha256 b5c28258b6c70494105ddc138fd6985430b9ba88512d117f056baa539f078491)
BibTeX
@misc{dc7b984ed76236,
  title = {USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I — Europe PMC PMID:41252204},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41252204},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b984ed76236; sha256 b5c28258b6c70494105ddc138fd6985430b9ba88512d117f056baa539f078491},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41252204. Agents can read the archived copy with the MCP tool read_document.